Actoxumab/Bezlotoxumab

N/A

Report date: 2024/06/07 17:49:42

Base Information

Drug NameActoxumab/Bezlotoxumab
Drug Alias Name้˜ฟๅ…‹ๆ‰˜ๅ•ๆŠ—/่ดๆด›ๆ‰˜่ˆ’ๅ•ๆŠ—Actoxumab/BezlotoxumabumActoxumab/CDB1้˜ฟๅกๅ•ๆŠ—/่ดๆด›ๆ‰˜ไบบๅ•ๆŠ—actoxumab+bezlotoxumab +[13]ย 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionToxin B inhibitorsBotulinum toxin inhibitorsToxin A inhibitors
TargetsToxin AToxin BBotulinum toxin
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes BezlotoxumabActoxumab
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A